Bladder Cancer
Comprehensive multiplexed autoantibody profiling of patients with advanced urothelial cancer.
February 5, 2024
Standardization of the evaluation and surveillance of patients with BCG unresponsive high grade non-muscle invasive bladder cancer clinical trials.
February 5, 2024
Management of patients with muscle-invasive bladder cancer with clinical evidence of pelvic lymph node metastases.
February 2, 2024
Microbiome Profiling in Bladder Cancer Patients Using the First-morning Urine Sample.
February 2, 2024
New Photocure White Paper addressing Inequality in Bladder Cancer Care and the importance of Real World Evidence
February 1, 2024
Perioperative and Complication-Related Outcomes for Robotic-Assisted versus Open Radical Cystectomy: A Comparative NSQIP Analysis.
February 1, 2024
Tumour tissue-derived small extracellular vesicles reflect molecular subtypes of bladder cancer.
February 1, 2024
Near-infrared photoimmunotherapy targeting Nectin-4 in a preclinical model of bladder cancer.
January 31, 2024
Evaluation of a New Cystoscopic Cryocatheter and Method for the In Situ Destruction of Bladder Cancer: Preliminary In vivo Study.
January 30, 2024
A Comprehensive Analysis of Immune Response in Patients with Non-Muscle-Invasive Bladder Cancer.
January 29, 2024
The Elusive Horizon: Biomarkers in Urothelial Carcinoma.
January 29, 2024
Immunomodulatory effects and improved outcomes with cisplatin- versus carboplatin-based chemotherapy plus atezolizumab in urothelial cancer.
January 29, 2024